← Back to Analyst Consensus 
FLGT Hold
Fulgent Genetics, Inc.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 4, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| May 5, 2026 | Piper Sandler | reiterate | Neutral → Neutral | — | 54% |
| Nov 11, 2025 | Piper Sandler | maintain | Neutral → Neutral | $30 | 54% |
| Aug 5, 2025 | UBS | upgrade | Neutral → Buy | $30 | 54% |
| Aug 4, 2025 | Piper Sandler | maintain | Neutral → Neutral | $21 | 54% |
| May 6, 2025 | Piper Sandler | maintain | Neutral → Neutral | $23 | 54% |
| May 5, 2025 | Raymond James | reiterate | Outperform → Outperform | $25 | 54% |
| Mar 4, 2025 | Piper Sandler | maintain | Neutral → Neutral | $16 | 54% |
| Nov 11, 2024 | Piper Sandler | maintain | Neutral → Neutral | $22 | 54% |
| Mar 6, 2024 | Piper Sandler | maintain | Neutral → Neutral | $25 | 54% |
| Dec 7, 2023 | UBS | initiate | — → Neutral | $35 | 54% |
| Oct 16, 2023 | Piper Sandler | maintain | Neutral → Neutral | $28 | 54% |
| Mar 2, 2023 | Credit Suisse | maintain | — → Outperform | $45 | — |
| Dec 8, 2022 | Piper Sandler | downgrade | Overweight → Neutral | $40 | 54% |
| Nov 18, 2022 | Raymond James | initiate | — → Outperform | $45 | 54% |
| Nov 14, 2022 | Credit Suisse | maintain | — → Outperform | $50 | — |
| Nov 14, 2022 | Piper Sandler | maintain | — → Overweight | $65 | 54% |
| Aug 25, 2022 | Credit Suisse | initiate | — → Outperform | $65 | — |
| May 16, 2022 | Piper Sandler | maintain | — → Overweight | $70 | 54% |
| Jan 25, 2022 | Oppenheimer | maintain | — → Outperform | $125 | 52% |
| Aug 10, 2021 | Credit Suisse | maintain | — → Underperform | $65 | — |
| Mar 5, 2021 | Piper Sandler | maintain | — → Overweight | $140 | 54% |
| Feb 1, 2021 | Oppenheimer | maintain | — → Outperform | $130 | 52% |
| Jan 8, 2021 | Credit Suisse | downgrade | Neutral → Underperform | $0 | — |
| Nov 24, 2020 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Sep 25, 2020 | Credit Suisse | maintain | — → Neutral | $42 | — |
| Aug 20, 2020 | Oppenheimer | initiate | — → Outperform | $75 | 52% |
| Jul 27, 2020 | Piper Sandler | maintain | — → Overweight | $31 | 54% |
| Jun 17, 2020 | Piper Sandler | maintain | — → Overweight | $21 | 54% |
| May 29, 2020 | BTIG | initiate | — → Buy | $20 | 52% |
| May 5, 2020 | Credit Suisse | maintain | — → Neutral | $11 | — |
| Nov 5, 2019 | Piper Sandler | upgrade | Neutral → Overweight | $12.3 | 54% |
| Apr 26, 2019 | Credit Suisse | downgrade | Outperform → Neutral | $0 | — |
| May 9, 2018 | Credit Suisse | maintain | Outperform → Outperform | $5 | — |
| Mar 1, 2018 | Piper Sandler | downgrade | Overweight → Neutral | $0 | 54% |
| Mar 1, 2018 | Credit Suisse | maintain | Outperform → Outperform | $6 | — |
| Nov 7, 2017 | Credit Suisse | maintain | — → Outperform | $7.5 | — |
| Aug 8, 2017 | Credit Suisse | maintain | — → Outperform | $10 | — |
| Oct 24, 2016 | BTIG | initiate | — → Buy | $0 | 52% |
Price Target Trend
Mar 31, 2026 Latest: $19 Oct 23, 2026
EPS Estimates
+1q $-0.69
Lo: $-0.69 Hi: $-0.69
1 analysts 0y $-2.27
Lo: $-2.27 Hi: $-2.27
1 analysts +1y $-1.38
Lo: $-1.38 Hi: $-1.38
1 analysts 0q $-0.65
Lo: $-0.65 Hi: $-0.65
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days